Nasus Pharma (NSRX) Total Assets (2022 - 2025)
Nasus Pharma (NSRX) total assets from Dec 31, 2022 to Dec 31, 2025. The current Nasus Pharma (NSRX) total assets is $5M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Total Assets
Total Assets
Nasus Pharma (NSRX) Total Assets CAGR table
| Period | CAGR |
|---|---|
| 1 Year | +594.44% |
Annual Total Assets change of Nasus Pharma (NSRX)
| Year | Total Assets | Change |
|---|---|---|
| 2025 | $5M | +594.44% |
| 2024 | $720K | N/A |
| 2023 | $0 | N/A |
| 2022 | $0 | N/A |
Comparison Nasus Pharma (NSRX) total assets with competitors
Nasus Pharma (NSRX) total assets is $5.00M.
| Ticker | Name | Total Assets | Upside |
|---|---|---|---|
| NVO | Novo Nordisk | $559.22B | +11184320.00% |
| PFE | Pfizer Inc | $207.62B | +4152260.00% |
| JNJ | Johnson & Johnson | $200.89B | +4017780.00% |
| ABBV | Abbvie Inc | $136.46B | +2729160.00% |
| MRK | Merck & Co Inc | $128.69B | +2573600.00% |
| SNY | Sanofi | $128.02B | +2560380.00% |
| NVS | Novartis AG | $118.53B | +2370540.00% |
| LLY | Lilly(Eli) & Company | $116.58B | +2331420.00% |
| AZN | Astrazeneca plc | $114.02B | +2280200.00% |
| AMGN | AMGEN Inc | $92.50B | +1849980.00% |
| BMY | Bristol-Myers Squibb Company | $86.48B | +1729420.00% |
| GSK | GSK Plc | $82.91B | +1658007.00% |
| GILD | Gilead Sciences Inc | $56.28B | +1125460.00% |
| BIIB | Biogen Inc | $29.48B | +589562.00% |
| GRFS | Grifols SA | $20.10B | +401878.78% |
| OGN | Organon & Company | $13.00B | +259820.00% |
| AMRN | Amarin Corp | $645.76M | +12815.28% |
| SCLX | Scilex Holding Company | $293.63M | +5772.70% |
| MIRA | Mira Pharmaceuticals Inc | $9.46M | +89.27% |
| MDCX | MDCorp | $7.43M | +48.54% |
| MDCXW | Medicus Pharma Ltd warrant | $7.43M | +48.54% |